arrow_back Back to App

Lower Drug Costs for Low-Income Medicare Beneficiaries

This bill aims to reduce prescription drug costs for low-income individuals enrolled in Medicare Part D. Starting in 2024, copayments for generic drugs will be eliminated, and copayments for other drugs will be frozen at 2023 levels, with minor adjustments thereafter. This will help seniors and those with lower incomes pay less for their prescriptions, improving access to essential medications.
Key points
Beginning in 2024, low-income individuals in Medicare Part D will pay $0 for generic drugs.
Copayments for other drugs under Medicare Part D for low-income individuals will be frozen at 2023 levels, with future increases tied only to inflation.
These changes are designed to ease the financial burden of prescription drug costs for the most vulnerable Medicare beneficiaries.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5386
Sponsor: Rep. McGarvey, Morgan [D-KY-3]
Process start date: 2023-09-12
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Cutting Copays Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5386.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-12.

What are the main provisions?

Key points include:

  • Beginning in 2024, low-income individuals in Medicare Part D will pay $0 for generic drugs.
  • Copayments for other drugs under Medicare Part D for low-income individuals will be frozen at 2023 levels, with future increases tied only to inflation.
  • These changes are designed to ease the financial burden of prescription drug costs for the most vulnerable Medicare beneficiaries.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. McGarvey, Morgan [D-KY-3].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health Benefits